Nicholas Hoffman & Company’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
11,697
-2,159
-16% -$197K 0.02% 148
2026
Q1
$1.42M Sell
13,856
-218
-2% -$24.6K 0.03% 107
2025
Q4
$1.76M Buy
14,074
+43
+0.3% +$5.48K 0.04% 96
2025
Q3
$1.88M Sell
14,031
-18
-0.1% -$2.36K 0.05% 87
2025
Q2
$1.91M Buy
14,049
+2,546
+22% +$336K 0.05% 80
2025
Q1
$1.53M Buy
11,503
+246
+2% +$31.3K 0.06% 88
2024
Q4
$1.27M Sell
11,257
-164
-1% -$19K 0.05% 99
2024
Q3
$1.3M Buy
11,421
+14
+0.1% +$1.54K 0.05% 107
2024
Q2
$1.19M Sell
11,407
-140
-1% -$14.8K 0.06% 106
2024
Q1
$1.31M Sell
11,547
-2,240
-16% -$257K 0.07% 96
2023
Q4
$1.52M Buy
13,787
+377
+3% +$37.7K 0.09% 76
2023
Q3
$1.3M Sell
13,410
-140
-1% -$14.7K 0.1% 83
2023
Q2
$1.48M Buy
13,550
+260
+2% +$27.7K 0.06% 80
2023
Q1
$1.35M Buy
13,290
+236
+2% +$24.9K 0.12% 84
2022
Q4
$1.43M Buy
13,054
+20
+0.2% +$2.07K 0.15% 83
2022
Q3
$1.26M Buy
13,034
+522
+4% +$55.6K 0.06% 83
2022
Q2
$1.36M Buy
12,512
+433
+4% +$49.2K 0.06% 79
2022
Q1
$1.43M Buy
12,079
+29
+0.2% +$3.6K 0.06% 75
2021
Q4
$1.7M Buy
12,050
+379
+3% +$48.5K 0.05% 65
2021
Q3
$1.38M Sell
11,671
-15
-0.1% -$1.84K 0.24% 72
2021
Q2
$1.35M Buy
11,686
+1,424
+14% +$166K 0.24% 79
2021
Q1
$1.23M Buy
10,262
+147
+1% +$17.4K 0.25% 82
2020
Q4
$1.11M Sell
10,115
-501
-5% -$54.5K 0.26% 74
2020
Q3
$1.16M Buy
10,616
+41
+0.4% +$4.16K 0.31% 63
2020
Q2
$967K Sell
10,575
-673
-6% -$60.8K 0.28% 70
2020
Q1
$888K Buy
11,248
+1,712
+18% +$143K 0.3% 73
2019
Q4
$828K Buy
9,536
+74
+0.8% +$6.2K 0.23% 98
2019
Q3
$792K Sell
9,462
-39
-0.4% -$3.31K 0.24% 93
2019
Q2
$799K Sell
9,501
-54
-0.6% -$4.25K 0.25% 94
2019
Q1
$764K Buy
9,555
+63
+0.7% +$4.69K 0.25% 97
2018
Q4
$687K Buy
9,492
+1,395
+17% +$98K 0.24% 90
2018
Q3
$594K Buy
8,097
+4,122
+104% +$271K 0.2% 103
2018
Q2
$242K Buy
3,975
+283
+8% +$17.2K 0.09% 151
2018
Q1
$221K Buy
+3,692
New +$222K 0.09% 161

Other funds holding ABT

Nicholas Hoffman & Company's ABT Position: Q2 2026 in Review

Nicholas Hoffman & Company reduced its Abbott (ABT) stake by 16% in Q2 2026, selling an estimated $197K and leaving 11,697 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #148.

Nicholas Hoffman & Company first reported a position in ABT in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.91M in Q2 2025. 1,527 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Nicholas Hoffman & Company held 11,697 shares of Abbott worth $1.06M as of Q2 2026.
  • Nicholas Hoffman & Company sold 2,159 Abbott shares in Q2 2026, an estimated $197K.
  • Abbott made up 0.02% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #148 holding.
  • Nicholas Hoffman & Company first reported a position in Abbott in Q1 2018 and has held it in 34 quarters since.
  • Nicholas Hoffman & Company's Abbott position peaked at $1.91M in Q2 2025.
  • 1,527 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.